Leinco Technologies

Executive Summary

Leinco Technologies is a privately held US biotechnology company founded in 1996, specializing in custom antibody and protein development for life science research and diagnostics. Operating an ISO 9001:2015 certified facility in St. Louis, Missouri, the company provides high-quality reagents and contract manufacturing services to academic, pharmaceutical, and diagnostic clients. With nearly three decades of experience, Leinco has established a reputation for reliable, custom solutions in the antibody space, though it remains a niche player with limited public visibility. The company's focus on quality and customer-specific projects positions it well for steady growth, but its private status and lack of disclosed financials make near-term catalysts uncertain.

Upcoming Catalysts (preview)

• Q4 2026New Antibody Catalog Launch60% success
• TBDISO Certification Renewal or Expansion90% success